Rachel Slayton
Director, Office of Mathematical Modeling, Division of Healthcare Quality Promotion
U.S. Department of Health and Human Services Continue Reading Rachel Slayton
MIDAS Network Member
Paper Information
Title
Assessing the social cost and benefits of a national requirement establishing antibiotic stewardship programs to prevent Clostridioides difficile infection in US hospitals.
Abstract
Incorporating the economic value of morbidity and mortality risk reductions in economic evaluations of healthcare-associated infections will significantly increase the benefits resulting from prevention.
From 2015 to 2020, total net benefits of the intervention to the healthcare system range from $300 million to $7.6 billion when values for morbidity and mortality risk reductions are ignored. Including these values, the net social benefits of the intervention range from $21 billion to $624 billion with the annualized net benefit of $25.5 billion under our most likely outcome scenario.
infection prevention program (including staffing an antibiotic stewardship program) that incorporated value of statistical life estimates to obtain economic values associated with morbidity and mortality risk reductions.
infection cases, attributable deaths, and the value of statistical life which was used to estimate the economic value of morbidity and mortality risk reductions.
Journal
Antimicrobial resistance and infection control
Citation
Scott RD 2nd., Slayton RB, Lessa FC, Baggs J, Culler SD, McDonald LC, Jernigan JA. (2019). Assessing the social cost and benefits of a national requirement establishing antibiotic stewardship programs to prevent Clostridioides difficile infection in US hospitals. Antimicrobial resistance and infection control, (8)
MIDAS Authors